Marketscale Creates: YouTube’s Past, Present, and Future Role in Fostering a Media Career

 

YouTube is an often overlooked social media platform, disregarded for the more digestible, quickly-consumable content of Instagram or Twitter. But for videographers and cinematographers, it’s a primary tool for showing and sharing their work. “Marketscale Creates,” takes a look at the YouTube platform with guests Chris Murray and Marcos Rocha, YouTubers and media professionals. Since YouTube began in 2005, the media channel has evolved. So what is its function today and how can videographers use it to bolster their work and brand.

A wise film school professor once told Chris Murray, “To be a successful cinematographer, it’s more than just shooting. It’s ⅓ creative, ⅓ technical, and ⅓ managerial.” Those words have stuck, and continue to ring true today. Youtube falls under that umbrella of being a managerial tool, he explains, pushing creators to continuously create and connect. “Exposure is currency,” says Murray. YouTube is more than just a place to post portfolio work, it’s a tool for building network and community.

Marcos Rocha’s entry into a professional media career wasn’t so linear. Coming to the industry later in life, he says he owes everything he knows to YouTube. “Youtube is a film school,” he says, “everything you can find and need is out there.” Rocha’s utilized YouTube as a learning platform and accountability tool, pushing himself to publish content he was proud of on a regular basis.

As the two videographers continue to build their businesses through YouTube, they both agree on one piece of advice: provide value. Don’t get into YouTube to strike it rich and stumble into celebrity fame. “Create content because you want to create it,” says Rocha. Maintain an authentic sense of self when creating media on the platform. Chris says, “You’re building your brand and that’s all you need to focus on. What would you do to build yourself up?”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More